Sascha Goonewardena
Manage Your Profile
About
I am an Associate Professor of Medicine, the Associate Director of the Vascular Defense and Discovery Laboratory, and the inaugural Wolfe Immunocardiology Scholar in the Division of Cardiovascular Medicine at the University of Michigan. My research focuses on translational studies and the basic mechanisms of innate immune responses, including how innate immune cells respond to endogenous stress, how they modulate their responses in a context-dependent manner, and the molecular interactions between immune and non-immune cells during the initiation of inflammatory responses. I completed a postdoctoral fellowship at the University of Chicago, using murine models and systems biology approaches to elucidate the innate immune mechanisms underlying heart failure. As an NIH T32 postdoctoral fellow and during my K08 award (NIH/NHLBI), I employed multidimensional cytometry and bioinformatics (including transcriptomics, metabolomics, and proteomics) to investigate innate immune mechanisms behind chronic inflammatory diseases. Over the past several years, I have used cellular, molecular, and machine learning techniques to understand the immune mechanisms driving cardiometabolic disease. My lab has built on these concepts and technologies, utilizing RNA-seq, various proteomic platforms, flow/mass cytometry, and bioinformatics to study how immune dysfunction accelerates thrombotic and cardiovascular diseases. I also serve as the Principal Investigator on a CSR&D Merit award, an investigator-initiated industry contract in which I use a microfluidic proteomic platform I developed to examine circulating immune phenotypes in patients treated with a PCSK9 inhibitor. Additionally, I am a reviewer for high-impact medical journals and an associate editor of the Journal of Clinical Lipidology and Cardiovascular Drugs and Therapeutics, with over 70 manuscripts published.
Qualifications
-
ResidencyUniversity of Chicago Hospital, Internal Medicine, Chicago IL, United States
2004 - 2026
-
Postdoctoral Research FellowUniversity of Michigan–Ann Arbor, Immunology and Nanotechnology, Ann Arbor, United States
2009 - 2011
-
FellowshipUniversity of Michigan–Ann Arbor, Cardiovascular Medicine, Ann Arbor, United States
2007 - 2009
-
Postdoctoral Research FellowUniversity of Chicago Medical Center, Genomics/systems biology, Chicago, United States
2006 - 2007
-
InternshipUniversity of Chicago Hospitals, Internal Medicine, Chicago, IL, United States
2003 - 2004
Center Memberships
-
Center MemberTaubman Institute
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
Research Overview
Innate immunity and macrophage biolog
Heart Failure and Atherosclerotic Cardiovascular Disease
Vascular Biology
Recent Publications
-
Shadiow J, Mazo CE, Varshney P, Kim JJ, Ahn A, Chong SH, Lutz CA, Holmes CM, Munson ME, Schmidt BM, Goonewardena SN, Minshall RD, Solomon TPJ, Ludlow AT, Haus JM. FASEB Journal, 2026 Jun 30; 40 (12):Journal ArticleWound Healing and Angiogenic Profiling of Dermal Endothelial Cells Isolated From People With Type 2 Diabetes
DOI:10.1096/fj.202502874R -
Forrest IS, Petrazzini BO, Chen R, Blazer AD, Goonewardena SN, Huang KL, Cho J, Nadkarni GN, Charney AD, Rosenson RS, Rocheleau G, Jordan DM, Do R. Med, 2026 Jun 12; 7 (6):Journal ArticleCapturing multi-disease states on a spectrum with machine learning and routine clinical data
DOI:10.1016/j.medj.2026.101150 PMID: 42208537 -
Goonewardena SN, Azubuike-Osu SO. J Card Fail, 2026 Jun 9;Journal ArticleFrom Prognosis to Therapy: suPAR and the Inflammatory Frontier in Heart Failure.
DOI:10.1016/j.cardfail.2026.05.006 PMID: 42263932 -
Singh AP, Shabani P, Ismail A, Chaudhary R, Alzamrooni A, Luther T, Nho M, Lopez R, Soni C, Goonewardena SN, Hayek S, Abdel-Latif A. 2026 Jun 9;PreprintSoluble Urokinase Plasminogen Activator Receptor Primes Macrophages and Worsens Heart Failure with Preserved Ejection Fraction.
DOI:10.64898/2026.06.04.730230 PMID: 42327267 -
Rosenson RS, Velamuri DN, Muntner P, Goonewardena SN. Atherosclerosis, 2026 May 24; 120755Journal ArticleRemnant cholesterol - The transition from biomarker to risk factor.
DOI:10.1016/j.atherosclerosis.2026.120755 PMID: 42178199 -
Goonewardena SN, Rosenson RS. J Am Soc Nephrol, 2026 May 20;Journal ArticleInclisiran in CKD: A Therapeutic Answer to a Persistent Treatment Gap.
DOI:10.1681/ASN.0000001127 PMID: 42160189 -
Goonewardena SN, Yao S, Jurga T, Zhang L, Lloyd-Jones D, Damodaran D, Thyagarajan B, Jacobs DR, Shore S, Brandt EJ, Clish C, Tanriverdi K, Freedman JE, Patel CJ, Sarzynski MA, Emmer BT, Wilkins JT, Do R, Bittner V, Shah R, Georgakis MK, Rosenson RS, Murthy V. J Clin Invest, 2026 Apr 16;Journal ArticleLipoprotein(a)-Associated Proteomic Signature Predicts Cardiovascular Disease in Young Adults.
DOI:10.1172/JCI204287 PMID: 42012308 -
Rosenson RS, Goonewardena SN. Nat Med, 2026 Mar 3;Journal ArticleBase editing milestone for familial hypercholesterolemia.
DOI:10.1038/s41591-026-04220-0 PMID: 41776074
Featured News & Stories